---
title: "MGNX.US (MGNX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MGNX.US/news.md"
symbol: "MGNX.US"
name: "MGNX.US"
parent: "https://longbridge.com/en/quote/MGNX.US.md"
datetime: "2026-05-20T13:53:26.027Z"
locales:
  - [en](https://longbridge.com/en/quote/MGNX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MGNX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MGNX.US/news.md)
---

# MGNX.US (MGNX.US) — Related News

### [MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum](https://longbridge.com/en/news/286462189.md)
*2026-05-14T20:02:51.000Z*
> MacroGenics, Inc. will participate in the Stifel 2026 Virtual Targeted Oncology Forum on May 20, 2026, at 10:30 a.m. ET.

### [Barclays Reaffirms Their Buy Rating on MacroGenics (MGNX)](https://longbridge.com/en/news/286391219.md)
*2026-05-14T09:25:19.000Z*
> Barclays analyst Etzer Darout has reaffirmed a Buy rating on MacroGenics (MGNX) with a price target of $6.00. The analys

### [U.S. stock night trading opens with fluctuations: Cisco rises 20.30% in night trading; Macrogenics rises 7.25% in night trading](https://longbridge.com/en/news/286332126.md)
*2026-05-14T00:07:09.000Z*
> Cisco night trading rose 20.30%; Macrogenics night trading rose 7.25%; Leslies night trading rose 25.87%; Innoviz Tech n

### [Macrogenics | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 20.78 M](https://longbridge.com/en/news/286312808.md)
*2026-05-13T20:28:07.000Z*
### [Boehringer's earnings per share in the first quarter were 0.21 yuan, hitting an 8-year low, a decrease of 98% compared to the same period last year](https://longbridge.com/en/news/286241218.md)
*2026-05-13T10:25:54.000Z*
> Baorui Pharmaceutical announced its Q1 financial report, with revenue of NT$4.001 billion, a year-on-year decrease of 10

### [Baorui Financial Report / First Quarter Profit Plummets by 90%, EPS 0.21 Yuan, CDMO Business Order Momentum Remains Strong](https://longbridge.com/en/news/286216438.md)
*2026-05-13T07:35:48.000Z*
> Boryung (6472) announced its Q1 2026 financial report, with consolidated revenue of NT$4.001 billion, a year-on-year dec

### [](https://longbridge.com/en/news/286127750.md)
*2026-05-12T15:32:35.000Z*
> MacroGenics shares are trading higher after the company announced it will sell GMP Manufacturing to Bora Pharmaceuticals

### [MacroGenics Sells Maryland Biologics Manufacturing to Bora](https://longbridge.com/en/news/286105216.md)
*2026-05-12T12:56:00.000Z*
> MacroGenics has agreed to sell its Maryland biologics manufacturing operations to Bora Pharmaceuticals for $122.5 millio